Literature DB >> 35782018

Augmented in vitro and in vivo Profiles of Brimonidine Tartrate Using Gelatinized-Core Liposomes.

Seham A Elkheshen1, Rania M Hathout2, Engy A Abdel Azim3, Marwa A Fouly4, Nada M El Hoffy3.   

Abstract

Background: The low entrapment efficiency of the hydrophilic drugs such as brimonidine tartrate (BRT) in liposomes represents a challenge that requires interventions. Gelatinized core liposomes (GCLs) were fabricated to increase the drug entrapment, corneal penetration, and physical stability of the investigated molecule. Research Design and
Methods: GCLs encapsulating BRT were prepared and optimized utilizing D-optimal design (DOD). The effect of plasticizer incorporation on the physicochemical characteristics and on the in vivo performance was studied. The optimized formulations were investigated for pH, rheological properties, morphological characteristics, in vitro release profiles, biological performance, safety profile. The effects of storage and gamma sterilization were also investigated.
Results: The results revealed the great success of the prepared formulations to achieve high entrapment efficiency reaching 98% after a maturation period of 10 days. The addition of glycerol as plasticizer significantly minimized the particle size and shortened the maturation period to 7 days. The selected formulations were stable for 3 months after gamma sterilization. The formulations showed significant lowering of intra-ocular pressure (IOP) in glaucomatous rabbits with sustainment of the pharmacological effect for 24 hours compared to drug solution. Conclusions: Enhanced in vitro and in vivo profiles of brimonidine tartrate loaded gelatinized-core-liposomes were obtained.
© 2022 Abdel Azim et al.

Entities:  

Keywords:  BRT; D-optimal design; DOD; IOP; brimonidine tartrate; gelatin; gelatinized core liposomes; glaucoma; intra-ocular pressure; ocular drug delivery; plasticizer

Mesh:

Substances:

Year:  2022        PMID: 35782018      PMCID: PMC9243147          DOI: 10.2147/IJN.S370192

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  59 in total

1.  Studying the influence of formulation and process variables on Vancomycin-loaded polymeric nanoparticles as potential carrier for enhanced ophthalmic delivery.

Authors:  Carol Yousry; Seham A Elkheshen; Hanan M El-Laithy; Tamer Essam; Rania H Fahmy
Journal:  Eur J Pharm Sci       Date:  2017-01-13       Impact factor: 4.384

2.  Nano drug delivery systems and gamma radiation sterilization.

Authors:  F Sakar; A Y Özer; S Erdogan; M Ekizoglu; D Kart; M Özalp; S Colak; Y Zencir
Journal:  Pharm Dev Technol       Date:  2016-04-06       Impact factor: 3.133

3.  Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies.

Authors:  Rania M Hathout; Samar Mansour; Nahed D Mortada; Ahmed S Guinedi
Journal:  AAPS PharmSciTech       Date:  2007-01-05       Impact factor: 3.246

4.  Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: Augmented in-vivo efficacy and safe histological profile.

Authors:  Miral Shokry; Rania M Hathout; Samar Mansour
Journal:  Int J Pharm       Date:  2018-04-27       Impact factor: 5.875

5.  Formulation factors for preparing ocular biodegradable delivery system of 5-fluorouracil microparticles.

Authors:  M K Yeh; S M Tung; D W Lu; J L Chen; C H Chiang
Journal:  J Microencapsul       Date:  2001 Jul-Aug       Impact factor: 3.142

6.  Influence of Cross-Linker Concentration on the Functionality of Carbodiimide Cross-Linked Gelatin Membranes for Retinal Sheet Carriers.

Authors:  Jui-Yang Lai; Ya-Ting Li
Journal:  J Biomater Sci Polym Ed       Date:  2011       Impact factor: 3.517

7.  A study of microemulsion systems for transdermal delivery of triptolide.

Authors:  Huabing Chen; Xueling Chang; Ting Weng; Xiaozhi Zhao; Zhonghong Gao; Yajiang Yang; Huibi Xu; Xiangliang Yang
Journal:  J Control Release       Date:  2004-08-27       Impact factor: 9.776

8.  In vitro and in vivo investigation for optimization of niosomal ability for sustainment and bioavailability enhancement of diltiazem after nasal administration.

Authors:  H O Ammar; M Haider; M Ibrahim; N M El Hoffy
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

9.  Niosome: A future of targeted drug delivery systems.

Authors:  Karim Masud Kazi; Asim Sattwa Mandal; Nikhil Biswas; Arijit Guha; Sugata Chatterjee; Mamata Behera; Ketousetuo Kuotsu
Journal:  J Adv Pharm Technol Res       Date:  2010-10

10.  Enhanced Allicin Cytotoxicity on HEPG-2 Cells Using Glycyrrhetinic Acid Surface-Decorated Gelatin Nanoparticles.

Authors:  Muhammed Ossama; Rania M Hathout; Dalia A Attia; Nahed D Mortada
Journal:  ACS Omega       Date:  2019-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.